UCHL1 is a Parkinson's disease susceptibility gene
- PMID: 15048890
- DOI: 10.1002/ana.20017
UCHL1 is a Parkinson's disease susceptibility gene
Erratum in
- Ann Neurol. 2004 Jun;55(6):899. Toda, Taksushi [corrected to Toda, Tatsushi]
Abstract
The reported inverse association between the S18Y variant of the ubiquitin carboxy-terminal hydrolase L1 (UCHL1) gene and Parkinson's disease (PD) has strong biological plausibility. If confirmed, genetic association of this variant with PD may support molecular targeting of the UCHL1 gene and its product as a therapeutic strategy for PD. In this light, we performed a collaborative pooled analysis of individual-level data from all 11 published studies of the UCHL1 S18Y gene variant and PD. There were 1,970 cases and 2,224 unrelated controls. We found a statistically significant inverse association of S18Y with PD. Carriers of the variant allele (Y/Y plus Y/S vs S/S) had an odds ratio (OR) of 0.84 (95% confidence interval [CI], 0.73-0.95) and homozygotes for the variant allele (Y/Y vs S/S plus Y/S) had an OR of 0.71 (95% CI, 0.57-0.88). There was a linear trend in the log OR consistent with a gene dose effect (p = 0.01). The inverse association was most apparent for young cases compared with young controls. There was no evidence for publication bias and the associations remained significant after excluding the first published, hypothesis-generating study. These findings confirm that UCHL1 is a susceptibility gene for PD and a potential target for disease-modifying therapies.
Similar articles
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article. Review.
-
Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.Health Technol Assess. 2022 Oct;26(44):1-310. doi: 10.3310/ZUCE8371. Health Technol Assess. 2022. PMID: 36321689 Free PMC article.
-
Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.Health Technol Assess. 2024 Oct;28(73):1-230. doi: 10.3310/YAPL9347. Health Technol Assess. 2024. PMID: 39487661 Free PMC article.
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3. Syst Rev. 2024. PMID: 39593159 Free PMC article.
Cited by
-
Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease.Antioxid Redox Signal. 2012 Dec 1;17(11):1490-506. doi: 10.1089/ars.2011.4312. Epub 2012 Mar 20. Antioxid Redox Signal. 2012. PMID: 22315971 Free PMC article.
-
Clinical and genetic evaluation of 8 Polish families with levodopa-responsive parkinsonism.J Neural Transm (Vienna). 2005 Nov;112(11):1487-502. doi: 10.1007/s00702-005-0290-8. Epub 2005 Mar 23. J Neural Transm (Vienna). 2005. PMID: 15785861
-
A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in mouse embryonic fibroblast.Toxicol Sci. 2010 Apr;114(2):356-77. doi: 10.1093/toxsci/kfq003. Epub 2010 Jan 8. Toxicol Sci. 2010. PMID: 20061341 Free PMC article.
-
Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.PLoS Genet. 2009 Feb;5(2):e1000382. doi: 10.1371/journal.pgen.1000382. Epub 2009 Feb 13. PLoS Genet. 2009. PMID: 19214209 Free PMC article.
-
Postmortem studies in Parkinson's disease.Dialogues Clin Neurosci. 2004 Sep;6(3):281-93. doi: 10.31887/DCNS.2004.6.3/ahartmann. Dialogues Clin Neurosci. 2004. PMID: 22033507 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous